The cancer proteomic landscape and the HUPO Cancer Proteome Project

The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide.

[1]  Michael L. Gatza,et al.  Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.

[2]  E. Fung,et al.  Proteomic approaches to tumor marker discovery. , 2002, Archives of pathology & laboratory medicine.

[3]  E C Nice,et al.  From proteomics to personalized medicine: the road ahead , 2016, Expert review of proteomics.

[4]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[5]  R. Bast,et al.  Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[6]  D. Chan,et al.  The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[7]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[8]  Beatriz Carvalho,et al.  Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening , 2017, Annals of Internal Medicine.

[9]  Richard D. LeDuc,et al.  High-Throughput Analysis of Intact Human Proteins Using UVPD and HCD on an Orbitrap Mass Spectrometer. , 2017, Journal of proteome research.

[10]  B. Kuster,et al.  Mass-spectrometry-based draft of the human proteome , 2014, Nature.

[11]  Gilbert S Omenn,et al.  Advances of the HUPO Human Proteome Project with broad applications for life sciences research , 2017, Expert review of proteomics.

[12]  Mehdi Mesri,et al.  Linking cancer genome to proteome: NCI's investment into proteogenomics , 2014, Proteomics.

[13]  Daniel C. Liebler,et al.  Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction* , 2016, Molecular & Cellular Proteomics.

[14]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[15]  Michael P. Schroeder,et al.  In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. , 2015, Cancer cell.

[16]  Lydie Lane,et al.  Metrics for the Human Proteome Project 2016: Progress on Identifying and Characterizing the Human Proteome, Including Post-Translational Modifications. , 2016, Journal of proteome research.

[17]  Ronald J. Moore,et al.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.

[18]  H. Rodriguez,et al.  Collaboration to Accelerate Proteogenomics Cancer Care: The Department of Veterans Affairs, Department of Defense, and the National Cancer Institute's Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network , 2017, Clinical pharmacology and therapeutics.

[19]  Mehdi Mesri,et al.  Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. , 2013, Cancer discovery.

[20]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[21]  Suzanne Rose Huge Data-Sharing Project Launched. , 2016, Cancer discovery.

[22]  A. Nesvizhskii,et al.  Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification. , 2015, Journal of proteome research.

[23]  Leroy Hood,et al.  Systems Biology and P4 Medicine: Past, Present, and Future , 2013, Rambam Maimonides medical journal.

[24]  Gary D Bader,et al.  A draft map of the human proteome , 2014, Nature.

[25]  Pierre Thibault,et al.  The Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions* , 2013, Molecular & Cellular Proteomics.

[26]  Jiang Lan,et al.  Pathology, proteomics and the pathway to personalised medicine , 2018, Expert review of proteomics.

[27]  Gary D Bader,et al.  The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. , 2013, Journal of proteome research.